Varenismart 1mg, Varenicline Tartrate, Smoking Cessation, Online Pharmacy, ZarvyPharm
SMOKING CESSATION Nicotine Withdraw(Nicotine Free)

Varenismart 1mg Tablet

★★★★★
★★★★★
0

(0)

Generic For CHAMPIX
Active Ingredient VARENICLINE TARTRATE
Strength 1MG
Manufacturer HEALING PHARMA
Varenismart 1mg box with blister pack, front view showing product name and dosage clearly
Varenismart 1mg box angled with blister strip in front, tablets and packaging visible
Varenismart 1mg box close-up
Varenismart 1mg box with blister pack, front view showing product name and dosage clearly
Varenismart 1mg box angled with blister strip in front, tablets and packaging visible
Varenismart 1mg box close-up
Best available coupon applied for preview!
Use code ZARVY26 at checkout to get 15% OFF your order.
COUPON CODE
ZARVY26
15% OFF
Pack Size Price Per Unit Unit Price QTY CART Best Coupon Price
MAX DISCOUNT
1 BOX - 10 TABLETS $ 4.33 $ 43.30
$ 36.81
Apply ZARVY26 (-15%)
You save $ 6.50
3 BOXES - 30 TABLETS $ 2.83
35% $ 129.90
$ 85.00
$ 72.25
Apply ZARVY26 (-15%)
You save $ 12.75
★ Best Value 6 BOXES - 60 TABLETS $ 2.39
45% $ 259.80
$ 143.30
$ 121.81
Apply ZARVY26 (-15%)
You save $ 21.50

Exchange & Returns Information

 

 

Reference

Reference information will be available soon.

Product Description

Varenismart 1mg Tablet contains varenicline tartrate, a selective partial agonist at α4β2 nicotinic acetylcholine receptors used as a first-line prescription therapy for smoking cessation. By partially stimulating these receptors it reduces nicotine withdrawal while blocking nicotine’s rewarding effects, increasing quit rates versus nicotine replacement alone. Available through licensed online pharmacy channels as part of structured 12-week quit programs with behavioral support.

Indications & Uses

  • Smoking Cessation / Nicotine Withdrawal — For adult smokers committed to quitting; improves abstinence when combined with counseling.
  • High Nicotine Dependence — Recommended for smokers who fail NRT or require stronger pharmacologic support.
  • Relapse Prevention — Used in standard 12-week courses; extension may be considered for relapse risk reduction.

Benefits & Effectiveness

  • Dual mechanism (partial agonist + antagonist) at α4β2 receptors reduces cravings and the rewarding effect of smoked nicotine, yielding superior quit rates vs. nicotine patch or gum.
  • Flexible quit strategies supported (set quit date 1–2 weeks after start, or quit between Days 8–35).
  • Predictable, titratable once-/twice-daily oral dosing that integrates well with behavioral counseling for long-term abstinence.

Directions for Use

  • Standard adult dosing (12-week regimen):
    Days 1–3: 0.5 mg orally once daily.
    Days 4–7: 0.5 mg orally twice daily.
    Days 8–84 (Weeks 2–12): 1 mg orally twice daily.
  • Administration notes: take with water after food to reduce nausea; swallow whole; maintain consistent dosing times.
  • Treatment planning: set a quit date ~1–2 weeks after initiation or quit between Days 8–35 while continuing therapy. Complete full 12-week course even if lapses occur.
  • Renal impairment: dose adjustment required in moderate–severe renal dysfunction—follow product-specific renal dosing guidance.
  • Monitoring: screen and monitor for mood or behavior changes, sleep disturbance, and renal function in elderly or those with kidney disease. Avoid heavy alcohol use during treatment.

Storage

  • Store in original packaging below 30°C, protected from light and moisture. Keep out of reach of children.

Possible Side Effects

  • Common: nausea (dose-related), vivid dreams/abnormal dreams, insomnia, headache, dry mouth, constipation/flatulence.
  • Occasional: anxiety, irritability, increased appetite.
  • Rare but serious: new or worsening depression, suicidal ideation or aggressive behavior, severe allergic reactions (angioedema).
  • Action: discontinue if severe neuropsychiatric symptoms or signs of hypersensitivity occur and evaluate promptly.

FAQs

Varenismart works directly on brain receptors rather than replacing nicotine, making it more effective at reducing cravings and satisfaction from smoking.
Begin 1–2 weeks before your planned quit date. Alternatively, quit smoking between Days 8 and 35 after starting treatment.
Behavioral support significantly improves success rates, especially during the high-risk relapse period after treatment ends.
It should be used cautiously in people with a history of psychiatric disorders. Regular monitoring is essential.
Even if relapse occurs, continue the medication as planned. A full course still increases the chance of quitting long term.

Ratings & Reviews

Reviewed by 0 Users

0/5
★★★★★
★★★★★
5★
0%
4★
0%
3★
0%
2★
0%
1★
0%

Write a Review:

✓ The 'Write a Review' button appears only when an order includes this product and the product item in that order is marked as 'Delivered'.

✓ Clicking the button will redirect you to 'My Account > Orders > Orders Processing', where you can leave a review for a delivered item.

💡 Each product item can be reviewed only once, after it has been marked as 'Delivered'.


Multiple orders:

✓ If you bought this product more than once on different days, you can write a separate review for each order.

💡 When Order A is marked 'Delivered', the button takes you to Order A's details page.

Later, when Order B is also marked Delivered, the button stays active and takes you to Order B's details page for another review.

No reviews yet. Be the first to review this product!

Alternatives

Combo Deals

No combo deals available at the moment.